Tips

From Other Journals

Transplantation Outcomes in Patients with Hepatitis C



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2002 Mar 1;65(5):966.

Hepatitis C virus (HCV) is a frequent cause of chronic liver disease, and HCV infection is the most common reason for liver transplantation. Better testing for HCV has improved diagnostic accuracy and shown a high frequency of HCV recurrence after transplantation that may lead to graft failure. Because organs for transplant are in limited supply, disease severity and expected outcomes should be considered when evaluating recipient candidates. Ghobrial and associates retrospectively studied the long-term clinical outcomes of patients who received a first-time transplant for end-stage HCV-induced liver disease.

Of the 510 patients included in the 10-year study period, 80 required retransplantation. Of the first-time transplant recipients, 59 received livers from persons known to be HCV-positive. All patients received maintenance immunosuppression. Patient survival rates were 84 percent at one year, 68 percent at five years, and 60 percent at 10 years, with higher mortality rates in patients with early HCV recurrence. These results are comparable with those occurring in patients who undergo liver transplantation for other indications. General survival rates and graft survival rates in patients who received a transplant from an HCV-positive donor were not different from those in patients with HCV-negative donors, although the period to histologic recurrence is shorter when an HCV-positive liver is used.

Mortality and Risk Factors* in Transplants for HCV-induced Hepatic Failure

Risk factors for decreased recipient survival

Increased age of recipient (> 52 years of age)

Preoperative serum creatinine level > 1 mg per dL (0.02 mmol per L)

More urgent UNOS status

Donor was female

Risk factors for decreased graft survival

Donor was female

Preoperative serum creatinine level > 1 mg per dL

Increased AST, ALT levels

More urgent UNOS status

Increased warm ischemia time


HCV = hepatitis C virus; UNOS = United Network for Organ Sharing; AST = aspartate transaminase; ALT = alanine transaminase.

*—Risk factors analyzed using univariate analysis.

Information from Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P, et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 2001;234:384–94.

Mortality and Risk Factors* in Transplants for HCV-induced Hepatic Failure

View Table

Mortality and Risk Factors* in Transplants for HCV-induced Hepatic Failure

Risk factors for decreased recipient survival

Increased age of recipient (> 52 years of age)

Preoperative serum creatinine level > 1 mg per dL (0.02 mmol per L)

More urgent UNOS status

Donor was female

Risk factors for decreased graft survival

Donor was female

Preoperative serum creatinine level > 1 mg per dL

Increased AST, ALT levels

More urgent UNOS status

Increased warm ischemia time


HCV = hepatitis C virus; UNOS = United Network for Organ Sharing; AST = aspartate transaminase; ALT = alanine transaminase.

*—Risk factors analyzed using univariate analysis.

Information from Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P, et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 2001;234:384–94.

Factors associated with increased risk of patient death after transplantation and with graft failure are listed in (see accompanying table). Increased pretransplant prothrombin time protected against graft failure.

The authors conclude that models can be developed to predict patient and graft survival in patients receiving liver transplants for HCV-related liver failure. These models may help current organ distribution systems to make appropriate decisions.

Ghobrial RM, et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg. September 2001;234:384–94.



Copyright © 2002 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

Navigate this Article